Intravenous Lorazepam Dosing and Administration Guidelines

Special Population Considerations

For elderly patients, the dose should be reduced by 20% or more due to reduced clearance, as recommended by medical guidelines 1

Monitor oxygen saturation and respiratory effort during administration, as recommended by the American Gastroenterological Association 2
Be prepared to support ventilation if needed, as there is an increased incidence of apnea when lorazepam is given rapidly IV or when combined with other sedative agents, according to the American Academy of Pediatrics 3
Respiratory depression is more likely in patients with underlying respiratory disease or when lorazepam is combined with opioids, as reported by the American Gastroenterological Association and medical guidelines 1 2

Lorazepam has a longer duration of action (1-24 hours) compared to midazolam (1-4 hours), as stated by the European Society of Cardiology 4

Be cautious with concomitant use of other CNS depressants, as this increases risk of respiratory depression, as warned by the American Gastroenterological Association and the American Academy of Pediatrics 2 3

Lorazepam is recommended as effective monotherapy for acute agitation in emergency settings, according to the American College of Emergency Physicians 5

The American Society of Clinical Oncology recommends reducing the dose of lorazepam by 20% or more in elderly patients, and using lower doses when combined with antipsychotics 6, 7
The American Society of Clinical Oncology also recommends using lower doses of lorazepam in patients with COPD or respiratory disease, due to the increased risk of respiratory depression 6, 7

The American Society of Clinical Oncology advises against underdosing in status epilepticus, as doses less than 4 mg significantly increase progression to refractory status, and against combining lorazepam with high-dose olanzapine due to fatality reports 6, 7
Additionally, the American Society of Clinical Oncology notes that benzodiazepines, including lorazepam, may paradoxically cause or worsen delirium and agitation 6, 7

The American College of Critical Care Medicine recommends lorazepam as the preferred benzodiazepine for acute severe anxiety in emergency or critical care settings, with a typical starting dose of 0.02-0.04 mg/kg (≤2 mg) administered slowly over several minutes, followed by maintenance dosing of 0.02-0.06 mg/kg every 2-6 hours as needed 8
Lorazepam is preferred over other benzodiazepines when IV access is available because it offers several clinical advantages, including a longer duration of action and more predictable pharmacokinetics 9, 8

Midazolam may be considered when rapid onset is essential, with a loading dose of 0.01-0.05 mg/kg IV over several minutes and maintenance of 0.02-0.1 mg/kg/hr continuous infusion 8

The standard adult dosing protocol for lorazepam is a loading dose of 0.02-0.04 mg/kg IV (maximum 2 mg per dose) administered over several minutes, followed by maintenance of 0.02-0.06 mg/kg every 2-6 hours as needed 8

The Society of Critical Care Medicine recommends mandatory monitoring of oxygen saturation and respiratory effort during IV benzodiazepine administration, and being prepared to support ventilation as needed 8